Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 155 Records) |
| Query Trace: Breast Neoplasms and CDH1[original query] |
|---|
| Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. The American journal of gastroenterology 2022 Sep . Stanich Peter P, Elgindi Dareen, Stoffel Elena, Koeppe Erika, Bansal Ajay, Stetson Rachel, Collins Debra L, Clark Dana Farengo, Karloski Eve, Dudley Beth, Brand Randall E, Hall Michael J, Chertock Yana, Sullivan Brian A, Muller Charles, Hinton Alice, Katona Bryson W, Kupfer Sonia |
| Identification of UCP1 and UCP2 as Potential Prognostic Markers in Breast Cancer: A Study Based on Immunohistochemical Analysis and Bioinformatics. Frontiers in cell and developmental biology 2022 7 10 891731. Yu Xin, Shi Manman, Wu Qi, Wei Wen, Sun Shengrong, Zhu Sh |
| ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 7 35 (12): 1804-1811. Grote Isabel, Bartels Stephan, Christgen Henriette, Radner Martin, Gronewold Malte, Kandt Leonie, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Graeser Monika, Kuemmel Sherko, Nitz Ulrike, Harbeck Nadia, Kreipe Hans, Christgen Matthi |
| High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing. NPJ breast cancer 2022 6 8 (1): 76. Kostecka Anna, Nowikiewicz Tomasz, Olszewski Pawe?, Koczkowska Magdalena, Horbacz Monika, Heinzl Monika, Andreou Maria, Salazar Renato, Mair Theresa, Madanecki Piotr, Gucwa Magdalena, Davies Hanna, Skokowski Jaros?aw, Buckley Patrick G, P?ksa Rafa?, ?rutek Ewa, Szylberg ?ukasz, Hartman Johan, Jankowski Micha?, Zegarski Wojciech, Tiemann-Boege Irene, Dumanski Jan P, Piotrowski Arkadiu |
| Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. Asian Pacific journal of cancer prevention : APJCP 2022 6 23 (6): 2027-2033. Gervas Polina, Molokov Aleksey, Babyshkina Nataliya, Kiselev Artem, Zarubin Aleksei, Yumov Evgeny, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
| Genome-wide linkage search for cancer susceptibility loci in a cohort of non BRCA1/2 families in Sri Lanka. BMC research notes 2022 Jun 15 (1): 190. Wijesiriwardhana Prabhavi, Musolf Anthony M, Bailey-Wilson Joan E, Wetthasinghe T Kalum, Dissanayake Vajira H |
| High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers. Journal of clinical medicine 2022 3 11 (6): . Voutsadakis Ioannis |
| Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Feb . LeNoue-Newton Michele L, Chen Sheau-Chiann, Stricker Thomas, Hyman David M, Blauvelt Natalie, Bedard Philippe L, Meric-Bernstam Funda, Punglia Rinaa S, Schrag Deborah, Lepisto Eva M, Andre Fabrice, Smyth Lillian, Dogan Semih, Yu Celeste, Wathoo Chetna, Levy Mia, Eli Lisa D, Xu Feng, Mann Grace, Lalani Alshad S, Ye Fei, Micheel Christine M, Arnedos Moni |
| Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. The Lancet. Oncology 2022 11 24 (1): 91-106. Garcia-Pelaez José, Barbosa-Matos Rita, Lobo Silvana, Dias Alexandre, Garrido Luzia, Castedo Sérgio, Sousa Sónia, Pinheiro Hugo, Sousa Liliana, Monteiro Rita, Maqueda Joaquin J, Fernandes Susana, Carneiro Fátima, Pinto Nádia, Lemos Carolina, Pinto Carla, Teixeira Manuel R, Aretz Stefan, Bajalica-Lagercrantz Svetlana, Balmaña Judith, Blatnik Ana, Benusiglio Patrick R, Blanluet Maud, Bours Vincent, Brems Hilde, Brunet Joan, Calistri Daniele, Capellá Gabriel, Carrera Sergio, Colas Chrystelle, Dahan Karin, de Putter Robin, Desseignés Camille, Domínguez-Garrido Elena, Egas Conceição, Evans D Gareth, Feret Damien, Fewings Eleanor, Fitzgerald Rebecca C, Coulet Florence, Garcia-Barcina María, Genuardi Maurizio, Golmard Lisa, Hackmann Karl, Hanson Helen, Holinski-Feder Elke, Hüneburg Robert, Krajc Mateja, Lagerstedt-Robinson Kristina, Lázaro Conxi, Ligtenberg Marjolijn J L, Martínez-Bouzas Cristina, Merino Sonia, Michils Geneviève, Novakovi? Srdjan, Patiño-García Ana, Ranzani Guglielmina Nadia, Schröck Evelin, Silva Inês, Silveira Catarina, Soto José L, Spier Isabel, Steinke-Lange Verena, Tedaldi Gianluca, Tejada María-Isabel, Woodward Emma R, Tischkowitz Marc, Hoogerbrugge Nicoline, Oliveira Car |
| Frequent cleft lip and palate in families with pathogenic germline CDH1 variants. Frontiers in genetics 2022 10 13 1012025. Green Benjamin L, Fasaye Grace-Ann, Samaranayake Sarah G, Duemler Anna, Gamble Lauren A, Davis Jeremy |
| Association of Pathway Mutations With Survival in Taiwanese Breast Cancers. Frontiers in oncology 2022 12 819555. Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu |
| Frequency of CDH1, CTNNA1 and CTNND1 Germline Variants in Families with Diffuse and Mixed Gastric Cancer. Cancers 2023 9 15 (17): . Joana Guerra, Carla Pinto, Pedro Pinto, Manuela Pinheiro, Catarina Santos, Ana Peixoto, Carla Escudeiro, Ana Barbosa, Miguel Porto, Inês Francisco, Paula Lopes, Ana Raquel Isidoro, Ana Luísa Cunha, Cristina Albuquerque, Isabel Claro, Carla Oliveira, João Silva, Manuel R Teixei |
| Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer. Frontiers in oncology 2023 8 13 1235902. Sarah Sammons, Andrew Elliott, Romualdo Barroso-Sousa, Saranya Chumsri, Antoinette R Tan, George W Sledge, Sara M Tolaney, Evanthia T Roussos Torr |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. Human genomics 2023 7 17 (1): 64. Neetha Nanoth Vellichirammal, Yuan-De Tan, Peng Xiao, James Eudy, Oleg Shats, David Kelly, Michelle Desler, Kenneth Cowan, Chittibabu Gu |
| Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
| Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. International journal of molecular sciences 2023 5 24 (10): . Orsolya Pipek, Donát Alpár, Orsolya Rusz, Csaba Bödör, Zoltán Udvarnoki, Anna Medgyes-Horváth, István Csabai, Zoltán Szállási, Lilla Madaras, Zsuzsanna Kahán, Gábor Cserni, Bence K?vári, Janina Kulka, Anna Mária T?k |
| Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy. Human genomics 2023 5 17 (1): 43. Nermine H Zakaria, Doaa Hashad, Marwa H Saied, Neamat Hegazy, Alyaa Elkayal, Eman Tay |
| Pathology-supported genetic testing for the application of breast cancer pharmacodiagnostics: family counselling, lifestyle adjustments and change of medication. Expert review of molecular diagnostics 2023 4 1-13. Okunola Abisola O, Baatjes Karin J, Zemlin Annalise E, Torrorey-Sawe Rispah, Conradie Magda, Kidd Martin, Erasmus Rajiv T, van der Merwe Nerina C, Kotze Maritha |
| Association of ATM, CDH1 and TP53 genes polymorphisms with familial breast cancer in patients of Khyber Pakhtunkhwa, Pakistan. African health sciences 2023 3 22 (3): 145-154. Rahim Abdur, Zakiullah , Jan Asif, Ali Johar, Khuda Fazli, Muhammad Basir, Khan Hamayun, Shah Hussain, Akbar Ra |
| Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study. Breast cancer (Tokyo, Japan) 2023 3 . Kikuchi Mari, Gomi Naoya, Ueki Arisa, Osako Tomo, Terauchi Takas |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Metastatic Breast Cancer to the Spine: Incidence of Somatic Gene Alterations and Association of Targeted Therapies With Overall Survival. Neurosurgery 2023 2 . Rabah Nicholas M, Jarmula Jakub, Hamza Omar, Khan Hammad A, Chakravarthy Vikram, Habboub Ghaith, Wright James M, Steinmetz Michael P, Wright Christina H, Krishnaney Ajit |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 525-530. Sukpan Panupong, Kanokwiroon Kanyanatt, Sriplung Hutcha, Laochareonsuk Wison, Choochuen Pongsakorn, Auseng Nasuha, Wanawanakorn Kasemsun, Sangkhathat Suras |
| The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients. European journal of medical research 2023 2 28 (1): 90. Cui Shengjin, Feng Jingying, Tang Xi, Lou Shuang, Guo Weiquan, Xiao Xiaowei, Li Shuping, Chen Xue, Huan Yu, Zhou Yiwen, Xiao Lij |
| Association of CDH1 Germline Variants and Colon Polyp Phenotypes in Patients with Hereditary Diffuse Gastric Cancer. Gastro hep advances 2023 2 2 (2): 244-251. Passi Monica, Gamble Lauren A, Samaranayake Sarah G, Schueler Samuel A, Curtin Bryan F, Fasaye Grace-Ann, Bowden Cassidy, Gurram Sandeep, Quezado Martha, Miettinen Markku, Koh Christopher, Heller Theo, Davis Jeremy |
| Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Human pathology 2023 11 . Baris Boyraz, Amy |
| PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS. Experimental oncology 2023 10 45 (2): 170-179. S Tabassum, F Munir, A A Al Awadh, Z Anw |
| Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants. European journal of breast health 2023 1 19 (1): 55-69. Suba??o?lu Asl?, Güç Zeynep Gülsüm, Gür Emine Özlem, Tekindal Mustafa Agah, Atahan Murat Kem |
| ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 2023 1 19 (1): e1010563. Ferrando Lorenzo, Vingiani Andrea, Garuti Anna, Vernieri Claudio, Belfiore Antonino, Agnelli Luca, Dagrada Gianpaolo, Ivanoiu Diana, Bonizzi Giuseppina, Munzone Elisabetta, Lippolis Luana, Dameri Martina, Ravera Francesco, Colleoni Marco, Viale Giuseppe, Magnani Luca, Ballestrero Alberto, Zoppoli Gabriele, Pruneri Giancar |
| Genomic characterisation of hormone receptor-positive breast cancer arising in very young women. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Luen S J, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell'Orto P, Biasi O, Degasperi A, Brown L C, Láng I, MacGrogan G, Tondini C, Bellet M, Villa F, Bernardo A, Ciruelos E, Karlsson P, Neven P, Climent M, Müller B, Joshum W, Bonnefoi H, Martino S, Davidson N E, Geyer C, Chia S K, Ingle J N, Coleman R, Solbach C, Thürlimann B, Colleoni M, Coates A S, Goldhirsch A, Fleming G F, Francis P A, Speed T P, Regan M M, Loi |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: